API
< Back to all clusters
[POLITICS] · United States · 36 sources

started · updated

White House withdraws FDA nominee Heidi Overton

The White House has withdrawn the nomination of Dr. Heidi Overton to lead the Food and Drug Administration (FDA) on the eve of a scheduled Senate Health, Education, Labor and Pensions Committee vote. The decision follows significant bipartisan skepticism and internal political pressure.

Overton, a physician and White House domestic policy adviser, faced opposition from several Republican senators. Concerns included her stance on childhood vaccinations, specifically her support for plans to break up combination vaccines like the MMR shot. Additionally, she faced scrutiny from pro-life senators regarding the administration’s handling of the abortion pill mifepristone, and from abortion rights advocates concerning her personal record.

Reports also indicated friction between Overton and Health and Human Services Secretary Robert F. Kennedy Jr., with some sources describing their relationship as “icy.” Members of the “Make America Healthy Again” (MAHA) movement reportedly viewed her as an obstacle to their policy agenda.

Senate Health Committee Chair Bill Cassidy disputed the White House's claim that Overton lacked sufficient votes, stating he believed she would have passed both the committee and the full Senate. He suggested the administration withdrew her rather than providing the specific commitments sought by pro-life senators. The FDA has been without a permanent commissioner since May 2026.

Entities

Bill Cassidy · Food and Drug Administration · Heidi Overton · Marty Makary · Robert F. Kennedy Jr. · Roger Marshall · United States Senate · White House

Claims

What the coverage asserts, and how many sources carry each claim.

Sources